Diabetes mellitus, thyroid dysfunctions and osteoporosis: is there an association?

Journal of Diabetes & Metabolic Disorders

Morteza Mansourian⁷  Hossein Ansari⁵  Younes Mohammadi³  Rasool Mohammadi⁸  Hamid Asayesh⁶  Aziz Rezapour²  Hossien Shadpour Dashti¹  Mehrdad Aghaei¹  Hamid Reza Bazrafshan¹  Mostafa Qorbani⁴ 

[1] Bone joints & Connective Tissue Research Center, Golestan University of Medical Sciences, Gorgan, Iran;Hospital Management Research Center, Iran University of Medical Sciences, Tehran, Iran;Department of Epidemiology & Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran;Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran;Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran;Department of Medical Emergency, Qom University of Medical Sciences, Qom, Iran;Department of Health Education, Ilam University of Medical Sciences, Ilam, Iran;Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

关键词: Thyroid diseases;    Diabetes mellitus;    Bone density;    Osteoporosis;   

Others  :  806890
DOI  :  10.1186/2251-6581-12-38

 received in 2013-06-08, accepted in 2013-06-17,  发布年份 2013

【 摘 要 】

Background

Osteoporosis is the most common metabolic bone disease with complicated, multifactorial and heterogenic nature that has no known pathological cause. As the role of Diabetes Mellitus (DM) and thyroid dysfunctions in the prevalence of osteoporosis is not exactly known, therefore this study was designed to evaluate the probable association between osteoporosis with DM and thyroid dysfunctions in Iranian patients.

Methods

In this cross-sectional study, 300 subjects out of the total number of patients referring to Gorgan bone densitometry centers (3000subjects) were selected via random sampling method in 2009. Individual characteristics, DM, thyroid dysfunctions and densitometry results were collected from densitometry records. Data analysis was carried out by SPSS version 16 software and by using Chi square and T-test. The level of significance in all tests was considered 0.05.

Results

The mean of T-score in lumbar and femoral areas of diabetic patients were -0.87 ± 1.08 and -1.94 ± 1.33 and in patient with thyroid dysfunctions was -0.80 ± 1.09 and -1.64 ± 1.24 respectively. The mean of BMD in lumbar and femoral areas of diabetic patients were 0.96 ± 0.19 and 0.75 ± 0.19 and in patient with thyroid dysfunctions were 0.96 ± 0.17 and 0.76 ±0.19 respectively. The mean of BMI in osteoporotic subjects in the lumbar and femoral areas were 25.94 ± 5.62 and 26.95 ± 5.20 respectively. The association between BMI and BMD in the lumbar and femoral areas were statistically significant, but the association between DM and thyroid dysfunctions with BMD and T-score in the femoral and lumbar areas was not statistically significant (P-value > 0.05).

Conclusion

The results of current study show that there is no association between DM and thyroid dysfunctions with osteoporosis.

【 授权许可】

   
2013 Qorbani et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Khoury MJ: Genetic and epidemiologic approaches to the search for gene-environment interaction: the case of osteoporosis. Am J Epidemiol 1998, 147(2):1-2.
• [2]Osteoporosis and the burden of osteoporosis-related fractures Am J Manag Care 2011, 17:164-169.
• [3]National Osteoporosis Foundation (NOF): America’s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington DC: National Osteoporosis Foundation; 2002.
• [4]Walker-Bone K, Dennison E, Cooper C: Epidemiology of osteoporosis. Rheumatic Disease Clinics of North America journal 2001, 27(1):1-118.
• [5]Aghaei M, Bazr Afshan HR, Qorbani M: Bone mineral density in Iranian patients: Effects of age, sex, and body mass index. Open J Prev Med 2013, 3:128-131.
• [6]Becker DJ, Kilgore ML, Morrisey MA: The societal burden of osteoporosis. Curr Rheumatol Rep 2010, 12:186-191.
• [7]Isaia GC, Ardissone P, Stefano DM, et al.: Bone metabolism in type II diabetes mellitus. Acta Diabetol 1999, 36:35-38.
• [8]Leidig-Bruckner G, Ziegler R: Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001, 109:493-514.
• [9]Räkel A, Sheehy O, Rahme E, et al.: Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008, 34:193-205.
• [10]Bonds DE, Larson JC, Schwartz AV, et al.: Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab 2006, 91:3404-3410.
• [11]Vestergaard P: Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 2007, 18:427-444.
• [12]Cakir B, Odabasi E, Turan M, et al.: Secondary osteoporosis in women. a retrospective analysis. Arch Gynecol Obstet 2002, 266:214-217.
• [13]Fitzpatrick LA: Secondary causes of osteoporosis. Mayo Clin Proc 2002, 77:453-468.
• [14]Gennari C, Martini G, Nuti R: Secondary osteoporosis. Aging 1998, 10:214-224.
• [15]Stein E, Shane E: Secondary osteoporosis. Endocrinol Metab Clin N Am 2003, 32:115-134.
• [16]Riggs BL: Role of the vitamin-D endocrine system in the pathophysiology of postmenopausal osteoporosis. J Cell Biochem 2003, 88:209-215.
• [17]Simon J, Leboff M, Wright J, et al.: Fractures in the elderly and vitamin D. J Nutr Health Aging 2002, 6:406-412.
• [18]Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2003, 22:477-501.
• [19]Hirano Y, Kishimoto H, Haino H, et al.: The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 1999, 17:119-124.
• [20]Follis RH: Skeletal changes associated with hyperthyroidism. Bulletin of John Hopkins Hospital 1953, 92:405-409.
• [21]Genat HK, Cooper C, Poor G: Interim report and recommendation of the WHO taskforce for osteoporosis. Osteoporos Int 1999, 10:259-264.
• [22]Amiri M, Larijani B, Nabipour I, et al.: The prevalence of osteoporosis in 20-69 years old women in Bushehr port. Tebe Jonob Journal 2005, 1:61-69.
• [23]Pazhohi M, Hosaini R, Larijani B, et al.: Bone mineral density in postmenopausal women with type II diabetes mellitus compared with control group. Iran J Endocrinol Metab 2001, 3:161-169.
• [24]Albright F, Reifenstein EC: Parathyroid gland and metabolic bone disease. Uk: Williams and Wilkins Co; 1948. 1 st ed
• [25]Meema HE, Meema S: The relationship of diabetes mellitus and body weight to osteoporosis in elderly females. Can Med Assoc J 1967, 1:132-139.
• [26]Moghimi N, Rahimi E, Derakhshan S, et al.: Osteoporosis in postmenopausal diabetic women: prevalence and related factors. Iran J Nucl Med 2008, 16:28-33.
• [27]Roe TF, Mora S, Costin G: Vertebral bone density in insulin-dependent diabetic children. Metabolism 1991, 40:967-71.
• [28]Tuominen JT, Impivaara O, Puukka P, et al.: Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999, 22:1196-1200.
• [29]Valerio G, Puente A, Puente E-d: The lumbar bone mineral density is affected by longterm poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 2002, 58:266-272.
• [30]Liu EY, Wactawski-Wende J, Donahue RP: Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 2003, 26:2365-69.
• [31]Turner B, Vagula R, Devi SS: Osteoporosis, an understated complication of diabetes. USPharmacist 2009, 34:14-16.
• [32]Daele V, Stolk PL, Burger H: Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam study. Ann Intern Med 1995, 122:409-414.
• [33]Kontorigaa E, Wozniakb G, Papathanasiouc I, et al.: Comparative study of the relationship between osteoporosis and diabetes mellitus in Greek population. Abstracts/Bone 2009, 44:339-450.
• [34]Lee WY, Oh KW, Rhee EJ, et al.: Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch Med Res 2006, 37:511-516.